Pre-diagnostic telomere length and colorectal cancer risk

Cancer Epidemiol. 2022 Apr:77:102100. doi: 10.1016/j.canep.2022.102100. Epub 2022 Jan 13.

Abstract

Background: Progressive telomere shortening may be related to genomic instability and carcinogenesis. Prospective evidence relating telomere length (TL) with colorectal cancer (CRC) risk has been limited and inconsistent.

Methods: We examined the association between pre-diagnostic peripheral blood leukocyte TL and CRC risk in two matched case-control studies nested within the Nurses' Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS). Relative leukocyte TL was measured using qPCR among 356 incident CRC cases and 801 controls (NHS: 186/465, HPFS: 170/336).

Results: We did not find a significant association between pre-diagnostic TL and CRC risk [in all participants, multivariable-adjusted odds ratio (OR) (95% CI) for TL Quartile 1 (shortest) vs. Quartile 4 (longest) = 1.36 (0.85, 2.17), P-trend = 0.27; OR (95% CI) per 1 SD decrease in TL = 1.12 (0.92, 1.36)].

Conclusions: Our prospective analysis did not support a significant association between pre-diagnostic leukocyte TL and CRC risk.

Keywords: Colon cancer; Colorectal cancer; Nested case-control study; Peripheral blood leukocyte; Rectal cancer; Telomere length.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Colorectal Neoplasms* / diagnosis
  • Colorectal Neoplasms* / epidemiology
  • Colorectal Neoplasms* / genetics
  • Follow-Up Studies
  • Humans
  • Leukocytes
  • Risk Factors
  • Telomere* / genetics